All‐cause mortality · patients with acute pancreatitis
Enteral may leads to lower mortality compared with parenteral nutrition (low certainty).
1 finding from 1 review
Length of hospital stay · patients with acute pancreatitis
1 finding from 1 review
Multiple Organ Failure(MOF) · patients with acute pancreatitis
Enteral probably leads to lower multiple Organ Failure(MOF) compared with parenteral nutrition (moderate certainty).
1 finding from 1 review
Operative Intervention · patients with acute pancreatitis
Enteral probably leads to lower operative Intervention compared with parenteral nutrition (moderate certainty).
1 finding from 1 review
Incidence of systemic infection · patients with acute pancreatitis
Enteral probably leads to lower systemic infection compared with parenteral nutrition (moderate certainty).
1 finding from 1 review
Local septic complications · patients with acute pancreatitis
Enteral showed no clear difference in local septic complications compared with parenteral nutrition (moderate certainty).
1 finding from 1 review
Remission · induction of remission in Crohn's disease
It is very uncertain whether enteral nutrition changes remission rate ‐ ITT compared with corticosteroids (very low certainty).
1 finding from 1 review
Remission rate ‐ ITT adult studies · induction of remission in Crohn's disease
It is very uncertain whether enteral nutrition changes remission rate ‐ ITT adult studies compared with corticosteroids (very low certainty).
1 finding from 1 review
Remission rate ‐ ITT pediatric studies · induction of remission in Crohn's disease
It is very uncertain whether enteral nutrition changes remission rate ‐ ITT pediatric studies compared with corticosteroids (very low certainty).
1 finding from 1 review
Remission rate ‐ per‐protocol ‐ pediatric studies · induction of remission in Crohn's disease
It is very uncertain whether enteral nutrition changes remission rate ‐ per‐protocol ‐ pediatric studies compared with corticosteroids (very low certainty).
1 finding from 1 review
Adverse events · induction of remission in Crohn's disease
It is very uncertain whether enteral nutrition changes adverse events compared with corticosteroids (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · induction of remission in Crohn's disease
It is very uncertain whether enteral nutrition changes withdrawal due to adverse events compared with corticosteroids (very low certainty).
1 finding from 1 review
Relapse · Participants with Crohn's disease in remission
It is very uncertain whether enteral nutrition changes relapse compared with 6‐MP (very low certainty).
1 finding from 1 review
Change in weight (kg) · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in height · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in quality of life · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · Participants with Crohn's disease in remission
Enteral nutrition showed no clear difference in adverse events compared with 6‐MP (low certainty).
1 finding from 1 review
Serious adverse events · Participants with Crohn's disease in remission
1 finding from 1 review
Withdrawals due to adverse events · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse · Participants with Crohn's disease in remission
Enteral nutrition showed no clear difference in relapse compared with mesalamine (low certainty).
1 finding from 1 review